Lexeo Therapeutics, Inc.
LXEO· Nasdaq
derived · Computed from the longer spans the company filed.
No earnings release is on file for this quarter. Its figures came with the 10-Q.
no prior Q4 2021 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lexeo Therapeutics, Inc. · CIK 1907108 · Engraved from SEC EDGAR